Skip to main content
SpringerLink
Log in

Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland

  • Letter to the Editor
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K et al (2013) Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152:714–726

    Article  CAS  PubMed  Google Scholar 

  2. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W et al (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470:115–119

    Article  CAS  PubMed  Google Scholar 

  3. Rossi D, Ciardullo C, Gaidano G (2013) Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies. Semin Cancer Biol, in press

  4. Landgren O, Staudt L (2012) MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med 367:2255–2256, author reply 2256–2257

    Article  CAS  PubMed  Google Scholar 

  5. Staedtler F, Suter W, Martus HJ (2004) Induction of A:T to G:C transition mutations by 5-(2-chloroethyl)-2′-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogue, in the bone marrow of Muta Mouse. Mutat Res 568:211–220

    Article  CAS  PubMed  Google Scholar 

Download references

Consent

Written informed consent was obtained from the patient's family for publication of this case report with the accompanying images.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Molecular Pathology, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan

    Koto Fujiishi, Riko Kitazawa, Yusa Nagai, Takafumi Watanabe, Ryuma Haraguchi & Sohei Kitazawa

  2. Section of Diagnostic Pathology, Saiseikai Imabari Hospital, Kitamura 7-1-6, Imabari City, Ehime, 799-1502, Japan

    Kenji Bando

  3. Department of Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, 791-0295, Japan

    Shinji Kobayashi & Yoshihiro Yakushijin

Authors
  1. Koto Fujiishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riko Kitazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusa Nagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takafumi Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenji Bando
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinji Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshihiro Yakushijin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ryuma Haraguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sohei Kitazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sohei Kitazawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujiishi, K., Kitazawa, R., Nagai, Y. et al. Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland. Virchows Arch 464, 121–124 (2014). https://doi.org/10.1007/s00428-013-1514-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-013-1514-1

Keywords

Search

Navigation